ofloxacin has been researched along with ro13-9904 in 99 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (3.03) | 18.7374 |
1990's | 21 (21.21) | 18.2507 |
2000's | 46 (46.46) | 29.6817 |
2010's | 25 (25.25) | 24.3611 |
2020's | 4 (4.04) | 2.80 |
Authors | Studies |
---|---|
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Addiss, SS | 1 |
Bhutta, ZA; Farooqui, BJ; Naqvi, SH | 1 |
Gürdal, H; Tulunay, FC; Usanmaz, S | 1 |
Benes, S; Covino, JM; Cummings, M; Draft, K; McCormack, WM; Smith, B | 1 |
Hayran, M; Kocagöz, T; Sener, B; Ustaçelebi, S | 1 |
Daschner, F; Kropec, A | 1 |
Acar, S; Ceyhan, M; Korten, V; Mert, A; Ovünç, K; Ulaş, T | 1 |
Bauer, D; Spohr, M; Traub, WH | 1 |
Day, NP; Diep, TS; Duong, NM; Ha, HD; Hien, TT; Hoa, NT; Smith, MD; Wain, J; White, NJ | 1 |
Bux, D; Hasan, M; Rathore, MH | 1 |
Giron, KP; Gross, ME; Musher, DM; Tharappel, RA; Williams, TW | 1 |
Bourlinou, PK; Karachalios, GN; Nasiopoulou, DD; Reppa, A | 1 |
Amiel, C; Baty, V; Canton, P; Garin, H; Hoen, B; Reyrolle, M; Schuhmacher, H | 1 |
Dunbar, L; File, TM; Kohler, R; Kojak, C; Player, R; Rubin, A; Segreti, J; Williams, RR | 1 |
Majtán, V; Majtánová, L | 1 |
Kahn, J; Mauriz, Y; Ogilvie, P; Thornsberry, C | 1 |
Tuohy, M; Washington, JA | 1 |
Norrby, SR; Petermann, W; Salewski, E; Vetter, N; Willcox, PA | 1 |
Appelbaum, PC; Hoellman, DB; Jacobs, MR; Lin, G | 1 |
Caldelari, I; Entenza, JM; Glauser, MP; Moreillon, P | 1 |
Léophonte, P; Veyssier, P | 1 |
Bell, T; Benenson, R; Kellogg, J; Manzella, J; Pellerin, G; Pope, D; Robertson, M | 1 |
Bagilet, D; Diab, M; Javkin, E; Kalbermatter, V | 1 |
Altus, P; Flannery, MT; Le, M | 1 |
Elliott, TB; Harding, RA; Henderson, PL; Landauer, MR; Ledney, GD; Tom, SP; Vigneulle, RM | 1 |
Abbas, KA; Hazir, T; Khan, MA; Qazi, SA | 1 |
Bosso, JA; Enzweiler, KA; Friedrich, LV; Hoban, D; Wagner, D; White, RL | 1 |
Bahal, N; Frank, E; Freitag, S; Kahn, JB; Kinasewitz, G; Liu, J; Moran, GJ; Olson, WH; Oross, MP; Reichl, V; Tennenberg, A; Wiesinger, BA | 1 |
Appelbaum, PC; Bozdogan, B; Browne, FA; Clark, C; Dewasse, BE; Jacobs, MR | 1 |
Castellano, G; Morillasa, JD; Pérez Carreras, M; Solís, JA; Tomás, ME | 1 |
Genitsariotis, R; Hahn, M; Jung, M; Kiesslich, R; Mäurer, M; Nafe, B; Will, D | 1 |
Choi, JH; Choi, SM; Kim, SH; Lee, DG; Shin, WS; Song, MJ; Yoo, JH | 1 |
Cottagnoud, M; Cottagnoud, P; Entenza, J; Flatz, L; Kühn, F; Stucki, A | 1 |
Hino, M; Iwata, Y; Kamimoto, A; Kinoshita, Y; Kobayashi, T; Oku, H; Yamane, T | 1 |
Alba, L; Antinori, A; Boumis, E; Festa, A; Marconi, P; Paglia, MG; Pucillo, LP; Visca, P | 1 |
Ambrosch, A; Dietlein, M; Kullmann, KH; Lehnert, H; Lobmann, R; Seewald, M; Zink, K | 1 |
Du, N; He, WP; Ji, W; Li, HW; Wang, HF; Xia, J; Zhao, P | 1 |
Di Bonaventura, G; Picciani, C; Piccolomini, R; Spedicato, I | 1 |
Abdulla, RH; Amsden, GW; Andrews, CP; de Caprariis, PJ; Knirsch, CA; Lode, H; Mandell, LA; McIvor, A; Niederman, MS; Vrooman, PS; Zervos, M | 1 |
González-Granda, D; Labrador, T; Martínez, I; Nieto, A; Querol-Borrás, JM; Querol-Ribelles, JM; Tenías, JM | 1 |
Gong, X; Mabey, D; Shang, S; Wang, Q; Xia, L; Zhang, J; Zhao, J; Zhong, M | 1 |
Bloom, C; Main, J; Thomson, EC | 1 |
Burgess, DS; Frei, CR | 1 |
Kenton, I; McKinnon, PS; Mohr, JF; Okhuysen, PC; Peymann, PJ; Septimus, E | 1 |
Drewelow, B; Hehl, EM; Klammt, S; Majcher-Peszynska, J; Mitzner, S; Müller, SC; Mundkowski, R; Peszynski, P; Schmidt, R; Stange, J; Wacke, R | 1 |
Harnett, J; Matchar, DB; Samsa, GP; Wilson, J | 1 |
Barberá Farré, JR; Carranza González, R; Fernández Cenjor, J; Prieto Gómez, E; Tena Gómez, D | 1 |
Dequin, PF; Garot, D; Legras, A; Mercier, E; Narciso, B; Perrotin, D; Rival, G | 1 |
Benhamou, Y; Cailleux, N; Lévesque, H; Marie, I; Plissonnier, D; Pons, JL; Richard, C; Watelet, J | 1 |
Asoh, N; Mizota, T; Nagatake, T; Oishi, K; Qin, L; Watanabe, H; Watanabe, K | 1 |
Cormier, G; Hamelin, JP; Lucas, V; Tanguy, G; Varin, S | 1 |
Gupta, N; Kumar, R | 1 |
Erkin, G; Isik, SR; Kalyoncu, AF; Karakaya, G | 1 |
Aradhyula, S; Greisnauer, S; Manian, FA; Meyer, PL; Senkel, D; Setzer, J; Wiechens, M | 1 |
Arguedas, A; Blumer, JL; Bradley, JS; Melkote, R; Noel, GJ; Sáez-Llorens, X | 1 |
Evers, T; Holman, A; Lloyd, A | 1 |
Beckius, ML; Fraser, SL; Galloway, RL; Griffith, ME; Hospenthal, DR; Mende, K; Miller, RS; Murray, CK; Pimentel, G; Ressner, RA | 1 |
Arvis, P; Carlet, J; Choudhri, S; Garau, J; Kureishi, A; Le Berre, MA; Lode, H; Read, RC; Torres, A; Winter, J | 1 |
Alsina, M; Calbo, E; Garau, J; Lite, J; Rodríguez-Carballeira, M | 1 |
Akhtar, N; Banerjee, P; Jain, TS; Thapa, R | 1 |
O'Connor, KM; Pergam, SA; Williams, P | 1 |
Béraud, G; Iba Ba, J; Legout, L; Mouton, Y; Senneville, E; Yazdanpanah, Y | 1 |
Abdi-Ali, A; Falsafi, T; Nikname, V; Rahmani-Badi, A | 1 |
Attridge, RT; Fisher, A; Frei, CR; Jaso, TC; Makos, BR; Mody, SH; Mortensen, EM; Oramasionwu, CU; Raut, MK; Restrepo, MI; Ruiz, AD; Ruiz, JL; Schein, JR | 1 |
Biswas, NK; Chandel, DS; Duggal, N; Duggal, S; Hans, C; Mahajan, RK | 1 |
Agarwala, S; Bakhshi, S; Gupta, A; Pandey, RM; Swaroop, C | 1 |
de la Fuente, J; Montero, J; Rodríguez, MI; Rodríguez, MS | 1 |
Gómez del Valle, C; Matía, M; Pérez-Calvo, JI; Torralba, MÁ | 1 |
Ejaz, M; Jabeen, K; Khan, E; Shezad, MF; Siddiqui, J; Zafar, A | 1 |
Castanheira, M; Jones, RN; Woosley, LN | 1 |
Gaborieau, V; Marchou, B; Weill, FX | 1 |
Akachi, S; Kondo, M; Kurokawa, I; Nishii, M; Yamanaka, K | 1 |
Bloch, J; Ferriby, D; Legout, L; Lemaire, X; Senneville, E; Yazdanpanah, Y | 1 |
Kim, JS; Kim, NY; Lee, KJ; Park, JS; Yun, HK | 1 |
Bohbot, JM | 1 |
Fantin, B; Lebeaux, D; Nicolas-Chanoine, MH; Petrover, D; Zarrouk, V | 1 |
Bansal, N; Chander, J; Kaistha, N | 1 |
Alba, LR; Jia, H; Kubin, CJ; Yoko Furuya, E | 1 |
Bielsa, S; Porcel, JM; Pubill-Fondevila, N | 1 |
Bourret, A; Brun, JL; Fauconnier, A | 1 |
Ge, X; Sun, H; Wang, H | 1 |
Andreeva, IV; Belikov, AN; Evstaf'ev, VV; Fokin, AA; Grinev, AV; Khrianin, AA; Kirpicheva, NN; Korolev, SV; Kozlov, SN; Serdiutskaia, MV; Stetsiuk, OU | 1 |
Balasubramanian, A; Mohamad, I; Sidek, D | 1 |
Coburn, B; Farrell, DJ; Jamieson, FB; Patel, SN; Rawte, P; Toye, B | 1 |
Grasso, DL; Lora, L; Muzzi, E; Orzan, E; Parentin, F; Pelos, G; Pensiero, S; Trabalzini, F | 1 |
Hensel, DJ; Scurlock, AM; Woods, JL | 1 |
Debata, NK; Jena, J; Sahoo, RK; Subudhi, E | 1 |
Khan, A; Koenekoop, RK; Mikhail, M | 1 |
Agostini, A; Bourret, A; Brun, JL; Derniaux, E; Fauconnier, A; Garbin, O; Graesslin, O; Huchon, C; Judlin, P; Lamy, C; Quentin, R; Verdon, R | 1 |
File, TM; LaPlante, K; Llop, CJ; Tillotson, GS; Tuttle, E | 1 |
Arjyal, A; Baker, S; Basnyat, B; Darton, T; Dolecek, C; Dongol, S; Farrar, JJ; Karkey, A; Thompson, CN; Thwaites, GE; Wolbers, M | 1 |
Guclu, E; Karabay, O; Okan, HD; Simsek, A | 1 |
Chongsuvivatwong, V; McNeil, E; Sangthong, R; Tang, R; Xu, J | 1 |
Baker, S; Day, NPJ; Parry, CM; Simpson, JA; Song Diep, T; Thanh Duy, P; Thi Diem Nga, L; Wain, J; White, NJ | 1 |
Green, MD; Khanthavong, M; Mayxay, M; Newton, PN; Phonlavong, C; Sengaloundeth, S; Sichanh, C; Swamidoss, I; Tabernero, P; Vilayhong, C | 1 |
Basnyat, B; Darton, TC; Eyre, D; Kuehn, R; Parry, CM; Stoesser, N | 1 |
3 review(s) available for ofloxacin and ro13-9904
Article | Year |
---|---|
[Management of uncomplicated pelvic inflammatory disease].
Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Chlamydia trachomatis; Drug Resistance, Microbial; Drug Therapy, Combination; Female; France; Gonorrhea; Humans; Metronidazole; Mycoplasma genitalium; Neisseria gonorrhoeae; Ofloxacin; Pelvic Inflammatory Disease; Sexual Partners; Tissue Adhesions | 2012 |
Updated French guidelines for diagnosis and management of pelvic inflammatory disease.
Topics: Anti-Infective Agents; Ceftriaxone; Disease Management; Drug Therapy, Combination; Female; France; Humans; Metronidazole; Ofloxacin; Pelvic Inflammatory Disease; Pelvis; Practice Guidelines as Topic; Societies, Medical; Ultrasonography | 2016 |
Treatment of enteric fever (typhoid and paratyphoid fever) with cephalosporins.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Cefixime; Ceftriaxone; Cephalosporins; Child; Chloramphenicol; Ciprofloxacin; Fluoroquinolones; Humans; Monobactams; Ofloxacin; Pakistan; Paratyphoid Fever; Recurrence; Typhoid Fever | 2022 |
21 trial(s) available for ofloxacin and ro13-9904
Article | Year |
---|---|
Comparison of ofloxacin and ceftriaxone in the treatment of uncomplicated gonorrhea caused by penicillinase-producing and non-penicillinase-producing strains.
Topics: Adult; Ceftriaxone; Chlamydia trachomatis; Female; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Ofloxacin; Penicillin Resistance; Penicillinase | 1990 |
Comparison of ofloxacin and ceftriaxone for short-course treatment of enteric fever.
Topics: Adolescent; Adult; Ceftriaxone; Drug Resistance, Microbial; Female; Humans; Male; Middle Aged; Ofloxacin; Typhoid Fever | 1994 |
Treatment of acute biliary tract infections with ofloxacin: a randomized, controlled clinical trial.
Topics: Anti-Infective Agents; Bacteremia; Ceftriaxone; Cephalosporins; Cholangitis; Cholecystitis; Escherichia coli Infections; Female; Gram-Negative Bacterial Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Ofloxacin; Phlebitis | 1996 |
A multicenter, randomized study comparing the efficacy and safety of intravenous and/or oral levofloxacin versus ceftriaxone and/or cefuroxime axetil in treatment of adults with community-acquired pneumonia.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Ceftriaxone; Cefuroxime; Cephalosporins; Community-Acquired Infections; Drug Therapy, Combination; Female; Humans; Injections, Intravenous; Levofloxacin; Male; Middle Aged; Ofloxacin; Pneumonia, Bacterial; Prodrugs; Prospective Studies; Treatment Outcome | 1997 |
A comparative study of levofloxacin and ceftriaxone in the treatment of hospitalized patients with pneumonia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Ceftriaxone; Cephalosporins; Community-Acquired Infections; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Hospitalization; Humans; International Cooperation; Levofloxacin; Male; Middle Aged; Ofloxacin; Pneumonia, Bacterial; Treatment Outcome | 1998 |
[Levofloxacin in the treatment of community-acquired pneumococcal pneumonia].
Topics: Adult; Aged; Amoxicillin; Anti-Infective Agents; Ceftriaxone; Cefuroxime; Clavulanic Acid; Community-Acquired Infections; Drug Therapy, Combination; Humans; Levofloxacin; Middle Aged; Ofloxacin; Pneumonia, Pneumococcal | 1999 |
[Oral levofloxacin versus intravenous ceftriaxone and amoxicillin/clavulanic acid in the treatment of community-acquired pneumonia that requires hospitalization].
Topics: Administration, Oral; Adult; Aged; Amoxicillin-Potassium Clavulanate Combination; Analysis of Variance; Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Cephalosporins; Community-Acquired Infections; Drug Therapy, Combination; Female; Humans; Injections, Intravenous; Levofloxacin; Male; Middle Aged; Ofloxacin; Pneumonia; Prospective Studies | 2000 |
A multicenter, open-label, randomized comparison of levofloxacin and azithromycin plus ceftriaxone in hospitalized adults with moderate to severe community-acquired pneumonia.
Topics: Adult; Aged; Aged, 80 and over; Azithromycin; Ceftriaxone; Community-Acquired Infections; Drug Therapy, Combination; Female; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Pneumonia; Severity of Illness Index | 2002 |
[Ceftriaxone versus Levofloxacin for antibiotic therapy in patients with acute cholangitis].
Topics: Acute Disease; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Bacteriological Techniques; Bile; Ceftriaxone; Cholangiopancreatography, Endoscopic Retrograde; Cholangitis; Data Interpretation, Statistical; Drug Resistance, Bacterial; Humans; Infusions, Intravenous; Levofloxacin; Metronidazole; Middle Aged; Ofloxacin; Prospective Studies; Time Factors | 2003 |
Antibiotic therapy for diabetic foot infections: comparison of cephalosporines with chinolones.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Ceftriaxone; Ciprofloxacin; Diabetic Foot; Female; Humans; Male; Middle Aged; Ofloxacin; Prospective Studies; Treatment Outcome | 2004 |
Comparative efficacies and tolerabilities of intravenous azithromycin plus ceftriaxone and intravenous levofloxacin with step-down oral therapy for hospitalized patients with moderate to severe community-acquired pneumonia.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Azithromycin; Canada; Ceftriaxone; Community-Acquired Infections; Drug Administration Schedule; Female; Germany; Humans; Infusions, Intravenous; Levofloxacin; Male; Ofloxacin; Pneumonia, Bacterial; Severity of Illness Index; Treatment Outcome; United States | 2004 |
Levofloxacin versus ceftriaxone plus clarithromycin in the treatment of adults with community-acquired pneumonia requiring hospitalization.
Topics: Aged; Anti-Bacterial Agents; Ceftriaxone; Clarithromycin; Cohort Studies; Community-Acquired Infections; Drug Therapy, Combination; Female; Hospitalization; Humans; Levofloxacin; Male; Ofloxacin; Pneumonia, Bacterial; Prospective Studies; Treatment Outcome | 2005 |
A cost-minimization analysis comparing azithromycin-based and levofloxacin-based protocols for the treatment of patients hospitalized with community-acquired pneumonia: results from the CAP-IN trial.
Topics: Aged; Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Community-Acquired Infections; Costs and Cost Analysis; Drug Therapy, Combination; Female; Home Care Services; Hospitalization; Humans; Length of Stay; Levofloxacin; Male; Ofloxacin; Pneumonia, Bacterial; United States | 2005 |
Short report: antimicrobial susceptibility and genetic characteristics of Haemophilus influenzae isolated from patients with respiratory tract infections between 1987 and 2000, including beta-lactamase-negative ampicillin-resistant strains.
Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactam Resistance; Ceftriaxone; Female; Haemophilus Infections; Haemophilus influenzae; Humans; Japan; Levofloxacin; Male; Microbial Sensitivity Tests; Ofloxacin; Respiratory Tract Infections | 2007 |
Multidrug-resistant typhoid fever.
Topics: Administration, Oral; Blood; Ceftriaxone; Chi-Square Distribution; Child; Child, Preschool; Drug Resistance, Multiple, Bacterial; Female; Humans; India; Infant; Infusions, Intravenous; Male; Microbial Sensitivity Tests; Ofloxacin; Probability; Prognosis; Prospective Studies; Risk Factors; Salmonella typhi; Severity of Illness Index; Survival Rate; Treatment Outcome; Typhoid Fever | 2007 |
Comparative study of levofloxacin in the treatment of children with community-acquired pneumonia.
Topics: Adolescent; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Ceftriaxone; Child; Child, Preschool; Clarithromycin; Community-Acquired Infections; Drug Therapy, Combination; Erythromycin; Female; Humans; Infant; Infant, Newborn; Levofloxacin; Male; Ofloxacin; Pneumonia; Treatment Outcome | 2007 |
A cost-minimisation analysis comparing moxifloxacin with levofloxacin plus ceftriaxone for the treatment of patients with community-acquired pneumonia in Germany: results from the MOTIV trial.
Topics: Administration, Oral; Aza Compounds; Ceftriaxone; Community-Acquired Infections; Cost of Illness; Cost-Benefit Analysis; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluoroquinolones; Follow-Up Studies; Hospitalization; Humans; Infusions, Intravenous; Length of Stay; Levofloxacin; Male; Moxifloxacin; Ofloxacin; Pneumonia, Bacterial; Prospective Studies; Quinolines; Severity of Illness Index; Treatment Outcome | 2008 |
Moxifloxacin monotherapy is effective in hospitalized patients with community-acquired pneumonia: the MOTIV study--a randomized clinical trial.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Aza Compounds; Bacteria; Ceftriaxone; Community-Acquired Infections; Double-Blind Method; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Levofloxacin; Male; Middle Aged; Moxifloxacin; Ofloxacin; Pneumonia, Bacterial; Prospective Studies; Quinolines; Severity of Illness Index; Treatment Outcome | 2008 |
Systemic expression of cytokine production in patients with severe pneumococcal pneumonia: effects of treatment with a beta-lactam versus a fluoroquinolone.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Ceftriaxone; Cytokines; Female; Humans; Interleukin 1 Receptor Antagonist Protein; Interleukins; Levofloxacin; Male; Middle Aged; Ofloxacin; Pneumonia, Pneumococcal; Prospective Studies; Time Factors; Tumor Necrosis Factor-alpha | 2008 |
Randomized controlled trial comparing oral amoxicillin-clavulanate and ofloxacin with intravenous ceftriaxone and amikacin as outpatient therapy in pediatric low-risk febrile neutropenia.
Topics: Administration, Oral; Adolescent; Ambulatory Care; Amikacin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Ceftriaxone; Child; Child, Preschool; Drug Therapy, Combination; Female; Fever; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Injections, Intravenous; Male; Neoplasms; Neutropenia; Ofloxacin; Treatment Outcome | 2009 |
Treatment Response in Enteric Fever in an Era of Increasing Antimicrobial Resistance: An Individual Patient Data Analysis of 2092 Participants Enrolled into 4 Randomized, Controlled Trials in Nepal.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Child; Drug Resistance, Multiple, Bacterial; Female; Fluoroquinolones; Gatifloxacin; Humans; Male; Microbial Sensitivity Tests; Nepal; Ofloxacin; Paratyphoid Fever; Salmonella paratyphi A; Salmonella typhi; Treatment Failure; Treatment Outcome; Typhoid Fever; Young Adult | 2017 |
75 other study(ies) available for ofloxacin and ro13-9904
Article | Year |
---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Treatment of choice for gonorrhea in Connecticut.
Topics: Ceftriaxone; Connecticut; Cost Control; Gonorrhea; Humans; Medical Indigency; Ofloxacin; Quality Assurance, Health Care | 1992 |
Therapy of multidrug resistant typhoid in 58 children.
Topics: Adolescent; Ampicillin Resistance; Aztreonam; Cefotaxime; Ceftriaxone; Child; Child, Preschool; Chloramphenicol Resistance; Drug Resistance, Microbial; Humans; Infant; Infant, Newborn; Ofloxacin; Salmonella typhi; Trimethoprim, Sulfamethoxazole Drug Combination; Typhoid Fever | 1992 |
The effects of ions on antibacterial activity of ofloxacin and ceftriaxone.
Topics: Cations; Ceftriaxone; Ofloxacin; Staphylococcus aureus | 1991 |
[The in vitro activity of ciprofloxacin against clinically-isolated strains of Pseudomonas aeruginosa and comparison with some other antibiotics].
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; Aztreonam; Ceftriaxone; Ciprofloxacin; Gentamicins; Humans; Ofloxacin; Pseudomonas aeruginosa | 1990 |
In vitro activity of fleroxacin and 6 other antimicrobials against Acinetobacter anitratus.
Topics: Acinetobacter; Anti-Bacterial Agents; Cefepime; Ceftazidime; Ceftriaxone; Cephalosporins; Ciprofloxacin; Enoxacin; Fleroxacin; Humans; Microbial Sensitivity Tests; Ofloxacin; Tobramycin | 1989 |
[Shigella serotypes and drug resistance patterns of strains isolated in Etimesgut, Turkey, in 1987].
Topics: Ampicillin Resistance; Anti-Bacterial Agents; Ceftriaxone; Chloramphenicol Resistance; Drug Resistance, Microbial; Dysentery, Bacillary; Humans; Nalidixic Acid; Ofloxacin; Prospective Studies; Serotyping; Shigella; Shigella boydii; Shigella flexneri; Shigella sonnei; Streptomycin; Tetracycline Resistance; Trimethoprim, Sulfamethoxazole Drug Combination; Turkey | 1988 |
Intraphagocytic bactericidal activity of ofloxacin compared with that of aztreonam and ceftriaxone against Serratia marcescens.
Topics: Aztreonam; Ceftriaxone; Escherichia coli; Humans; Ofloxacin; Oxazines; Phagocytes; Phagocytosis; Rifampin; Serratia marcescens | 1986 |
Multidrug-resistant Salmonella typhi in Pakistani children: clinical features and treatment.
Topics: Ampicillin Resistance; Anti-Infective Agents; Cefotaxime; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Chloramphenicol Resistance; Drug Resistance, Multiple; Female; Humans; Infant; Male; Ofloxacin; Pakistan; Salmonella typhi; Trimethoprim Resistance; Typhoid Fever | 1996 |
In vitro antimicrobial effect against Streptococcus pneumoniae of adding rifampin to penicillin, ceftriaxone, or 1-ofloxacin.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Cephalosporins; Colony Count, Microbial; Humans; Microbial Sensitivity Tests; Ofloxacin; Penicillin G; Pneumococcal Infections; Rifampin; Streptococcus pneumoniae | 1995 |
Legionella jordanis pneumonia unresponsive to fluoroquinolones in a non-immunocompromised host.
Topics: Aged; Anti-Infective Agents; Ceftriaxone; Drug Therapy, Combination; Erythromycin; Humans; Immunocompetence; Legionella; Legionellosis; Male; Ofloxacin; Pneumonia, Bacterial; Rifampin | 1997 |
Pharmacodynamic parameters of ofloxacin, tobramycin and ceftriaxone and their effect on the biological properties of salmonellae.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Cephalosporins; Coloring Agents; Congo Red; Microbial Sensitivity Tests; Ofloxacin; Salmonella; Salmonella enteritidis; Salmonella Phages; Salmonella typhimurium; Tobramycin | 1997 |
Surveillance of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States in 1996-1997 respiratory season. The Laboratory Investigator Group.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactamases; Ceftriaxone; Cefuroxime; Clarithromycin; Cohort Studies; Drug Resistance, Microbial; Haemophilus influenzae; Humans; Levofloxacin; Microbial Sensitivity Tests; Moraxella catarrhalis; Ofloxacin; Respiratory Tract Infections; Streptococcus pneumoniae; United States | 1997 |
Antimicrobial susceptibility of viridans group streptococci.
Topics: Amoxicillin; Anti-Bacterial Agents; Cefazolin; Ceftriaxone; Clindamycin; Drug Resistance, Microbial; Gentamicins; Humans; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Ofloxacin; Penicillins; Rifampin; Streptococcal Infections; Streptococcus; Thienamycins; Vancomycin; Virginiamycin | 1997 |
Anti-pneumococcal activity of gatifloxacin compared with other quinolone and non-quinolone agents.
Topics: Amoxicillin; Anti-Infective Agents; Ceftriaxone; Cefuroxime; Cephalosporins; Ciprofloxacin; Clarithromycin; Fluoroquinolones; Gatifloxacin; Levofloxacin; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Penicillin Resistance; Streptococcus pneumoniae | 1999 |
Efficacy of levofloxacin in the treatment of experimental endocarditis caused by viridans group streptococci.
Topics: Animals; Anti-Infective Agents; Catheterization; Ceftriaxone; Ciprofloxacin; Endocarditis, Bacterial; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Penicillin Resistance; Rats; Streptococcal Infections; Streptococcus; Streptococcus sanguis; Treatment Outcome | 1999 |
National guideline for the management of epididymo-orchitis. Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases).
Topics: Anti-Bacterial Agents; Ceftriaxone; Chlamydia trachomatis; Ciprofloxacin; Doxycycline; Epididymitis; Humans; Male; Neisseria gonorrhoeae; Ofloxacin; Orchitis; Sexually Transmitted Diseases | 1999 |
National guideline for the management of pelvic infection and perihepatitis. Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases).
Topics: Anti-Bacterial Agents; Cefoxitin; Ceftriaxone; Ciprofloxacin; Clindamycin; Contact Tracing; Female; Genital Diseases, Male; Humans; Male; Ofloxacin; Pelvic Inflammatory Disease; Peritonitis; Pregnancy; Pregnancy Complications, Infectious; Sexually Transmitted Diseases | 1999 |
Choice of antibiotic and risk of colonization with vancomycin-resistant Enterococcus among patients admitted for treatment of community-acquired pneumonia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Cephalosporins; Community-Acquired Infections; Drug Therapy, Combination; Enterococcus; Erythromycin; Female; Gram-Positive Bacterial Infections; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Pneumonia, Bacterial; Prospective Studies; Risk Factors; Vancomycin Resistance | 2000 |
Endocarditis due to Salmonella.
Topics: Aged; Anti-Infective Agents; Cardiac Catheterization; Ceftriaxone; Cephalosporins; Combined Modality Therapy; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Echocardiography, Transesophageal; Endocarditis, Bacterial; Fatal Outcome; Fever; Headache; Heart Valve Prosthesis Implantation; Humans; Male; Nausea; Ofloxacin; Rheumatic Heart Disease; Salmonella Infections; Vomiting | 2001 |
Survival of irradiated mice treated with WR-151327, synthetic trehalose dicorynomycolate, or ofloxacin.
Topics: Adjuvants, Immunologic; Animals; Anti-Infective Agents; Ceftriaxone; Cephalosporins; Cord Factors; Female; Gamma Rays; Gram-Negative Bacterial Infections; Liver; Mice; Mice, Inbred Strains; Neutrons; Ofloxacin; Organothiophosphorus Compounds; Radiation Injuries, Experimental; Radiation Tolerance; Radiation-Protective Agents; Survival Rate | 1994 |
Therapeutic re-appraisal of multiple drug resistant Salmonella typhi (MDRST) in Pakistani children.
Topics: Amoxicillin; Cefotaxime; Ceftriaxone; Child; Child, Preschool; Chloramphenicol; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Humans; Infant; Infusions, Intravenous; Male; Microbial Sensitivity Tests; Ofloxacin; Pakistan; Prognosis; Retrospective Studies; Salmonella typhi; Treatment Failure; Treatment Outcome; Typhoid Fever | 2002 |
Comparative activity of gatifloxacin and other antibiotics against 4009 clinical isolates of Streptococcus pneumoniae in the United States during 1999-2000.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Ceftriaxone; Child; Ciprofloxacin; Female; Fluoroquinolones; Gatifloxacin; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Penicillin Resistance; Penicillins; Pneumococcal Infections; Streptococcus pneumoniae; United States | 2002 |
Single and multi-step resistance selection study in Streptococcus pneumoniae comparing ceftriaxone with levofloxacin, gatifloxacin and moxifloxacin.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Ceftriaxone; Culture Media; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gatifloxacin; Humans; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Mutation; Ofloxacin; Quinolines; Selection, Genetic; Streptococcus pneumoniae | 2002 |
[Rupture of the Achilles' tendon secondary to levofloxacin].
Topics: Achilles Tendon; Adult; Ceftriaxone; Ciprofloxacin; Crohn Disease; Drug Therapy, Combination; Humans; Intestinal Perforation; Levofloxacin; Male; Methylprednisolone; Metronidazole; Ofloxacin; Rupture; Tendinopathy | 2003 |
Effect of moxifloxacin on production of proinflammatory cytokines from human peripheral blood mononuclear cells.
Topics: Adjuvants, Immunologic; Anti-Infective Agents; Aza Compounds; Blotting, Western; Ceftriaxone; Cell Survival; Cephalosporins; Cytokines; Enzyme-Linked Immunosorbent Assay; Escherichia coli; Flow Cytometry; Fluoroquinolones; Humans; I-kappa B Proteins; In Vitro Techniques; Interleukin-6; Lipopolysaccharide Receptors; Monocytes; Moxifloxacin; Ofloxacin; Quinolines; Streptococcus pneumoniae; Tumor Necrosis Factor-alpha | 2003 |
Ceftriaxone acts synergistically with levofloxacin in experimental meningitis and reduces levofloxacin-induced resistance in penicillin-resistant pneumococci.
Topics: Animals; Anti-Bacterial Agents; Ceftriaxone; Cephalosporins; DNA Topoisomerase IV; DNA, Bacterial; Drug Resistance, Bacterial; Drug Synergism; Levofloxacin; Meningitis, Pneumococcal; Microbial Sensitivity Tests; Ofloxacin; Penicillin Resistance; Rabbits; Reverse Transcriptase Polymerase Chain Reaction; Streptococcus pneumoniae | 2004 |
[A case of pseudothrombocytopenia during antibiotic administration].
Topics: Aged; Anti-Bacterial Agents; Ceftriaxone; Fatal Outcome; Female; Humans; Levofloxacin; Lung Diseases, Interstitial; Ofloxacin; Thrombocytopenia | 2004 |
Short Communication: Yersinia pseudotuberculosis septicemia in an HIV-infected patient failed HAART.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiretroviral Therapy, Highly Active; Ceftriaxone; Drug Therapy, Combination; Female; Humans; Levofloxacin; Ofloxacin; Sepsis; Treatment Failure; Yersinia pseudotuberculosis; Yersinia pseudotuberculosis Infections | 2004 |
[A prospective study on short period antibiotic treatment of hepatic failure complicated with spontaneous bacterial peritonitis].
Topics: Adult; Anti-Bacterial Agents; Bacterial Infections; Ceftriaxone; Drug Therapy, Combination; Female; Humans; Liver Failure; Male; Middle Aged; Ofloxacin; Peritonitis; Prospective Studies; Treatment Outcome | 2004 |
E-test method for detecting antibiotic synergy against Pseudomonas aeruginosa from neutropenic patients: a cost-effective approach.
Topics: Anemia; Anti-Bacterial Agents; Cefotaxime; Ceftriaxone; Cost-Benefit Analysis; Drug Synergism; Drug Therapy, Combination; Fluoroquinolones; Hematologic Neoplasms; Humans; Levofloxacin; Microbial Sensitivity Tests; Neutropenia; Ofloxacin; Piperazines; Pseudomonas aeruginosa; Pseudomonas Infections | 2004 |
In vitro effects of spectinomycin and ceftriaxone alone or in combination with other antibiotics against Chlamydia trachomatis.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Chlamydia trachomatis; Doxycycline; Drug Antagonism; Drug Synergism; Erythromycin; Microbial Sensitivity Tests; Ofloxacin; Spectinomycin | 2005 |
An elderly lady with sudden blindness and a sore foot.
Topics: Administration, Topical; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Blindness; Ceftriaxone; Chloramphenicol; Clindamycin; Dexamethasone; Endophthalmitis; Eye Enucleation; Female; Humans; Injections, Intravenous; Metatarsal Bones; Ofloxacin; Osteomyelitis; Streptococcal Infections; Streptococcus; Treatment Outcome | 2006 |
Pharmacodynamic analysis of ceftriaxone, gatifloxacin,and levofloxacin against Streptococcus pneumoniae with the use of Monte Carlo simulation.
Topics: Anti-Bacterial Agents; Area Under Curve; Ceftriaxone; Computer Simulation; Databases, Factual; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gatifloxacin; Humans; Injections, Intravenous; Levofloxacin; Microbial Sensitivity Tests; Monte Carlo Method; Ofloxacin; Streptococcus pneumoniae | 2005 |
A retrospective, comparative evaluation of dysglycemias in hospitalized patients receiving gatifloxacin, levofloxacin, ciprofloxacin, or ceftriaxone.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Blood Glucose; Ceftriaxone; Ciprofloxacin; Female; Fluoroquinolones; Gatifloxacin; Humans; Hyperglycemia; Hypoglycemia; Levofloxacin; Male; Middle Aged; Ofloxacin; Product Surveillance, Postmarketing; Retrospective Studies | 2005 |
Drugs in liver disease and during albumin dialysis -MARS.
Topics: Anti-Bacterial Agents; Blood Component Removal; Ceftazidime; Ceftriaxone; Extracorporeal Circulation; Humans; Liver Diseases; Metabolic Clearance Rate; Ofloxacin; Renal Dialysis; Serum Albumin; Teicoplanin | 2001 |
[Pneumonia by Corynebacterium pseudodiphteriticum: an infection to consider].
Topics: Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Ceftriaxone; Corynebacterium; Corynebacterium Infections; Diabetes Mellitus, Type 1; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Intubation, Intratracheal; Male; Multiple Trauma; Ofloxacin; Pneumonia, Bacterial; Prednisone; Pulmonary Disease, Chronic Obstructive; Sjogren's Syndrome; Smoking; Vancomycin | 2006 |
[Acute respiratory failure and septic shock induced by Mycobacterium bovis. A rare side effect of intravesical BCG therapy].
Topics: Acute Disease; Administration, Intravesical; Aged; Anti-Bacterial Agents; BCG Vaccine; Ceftriaxone; Humans; Male; Mycobacterium bovis; Ofloxacin; Respiratory Insufficiency; Shock, Septic; Urinary Bladder Neoplasms | 2006 |
[Infectious or inflammatory aortitis? One case report].
Topics: Adrenal Cortex Hormones; Aged; Anti-Bacterial Agents; Aortic Aneurysm, Abdominal; Aortic Dissection; Aortitis; Ceftriaxone; Drug Therapy, Combination; Emergencies; Female; Follow-Up Studies; Gentamicins; Humans; Ofloxacin; Pneumococcal Infections; Streptococcus pneumoniae; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2006 |
Yersinia pseudotuberculosis infection of a lumbar facet joint.
Topics: Anti-Bacterial Agents; Arthritis, Infectious; Ceftriaxone; Humans; Lumbar Vertebrae; Male; Middle Aged; Ofloxacin; Treatment Outcome; Yersinia pseudotuberculosis; Yersinia pseudotuberculosis Infections; Zygapophyseal Joint | 2007 |
Multidrug-induced erythema multiforme.
Topics: Adult; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Azithromycin; Ceftriaxone; Ciprofloxacin; Drug Hypersensitivity; Erythema Multiforme; Female; Humans; Levofloxacin; Methenamine; Ofloxacin; Piroxicam; Skin Tests; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 2007 |
Is it Clostridium difficile infection or something else? A case-control study of 352 hospitalized patients with new-onset diarrhea.
Topics: Aged; Analysis of Variance; Case-Control Studies; Cefazolin; Ceftriaxone; Clostridioides difficile; Confidence Intervals; Cross Infection; Diarrhea; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Female; Hospitalization; Humans; Incidence; Levofloxacin; Male; Missouri; Multivariate Analysis; Odds Ratio; Ofloxacin; Regression Analysis; Retrospective Studies; Risk Factors | 2007 |
Antimicrobial susceptibilities of geographically diverse clinical human isolates of Leptospira.
Topics: Ampicillin; Anti-Bacterial Agents; Azithromycin; Cefepime; Cefotaxime; Ceftriaxone; Cephalosporins; Ciprofloxacin; Egypt; Hawaii; Humans; Leptospira; Leptospirosis; Levofloxacin; Microbial Sensitivity Tests; Nicaragua; Ofloxacin; Tetracycline; Thailand | 2008 |
Transient dysautonomia and cerebellitis in childhood enteric fever.
Topics: Anti-Bacterial Agents; Ataxia; Autonomic Nervous System; Ceftriaxone; Cerebellar Diseases; Cerebellum; Child; Gait Disorders, Neurologic; Humans; Hypotension; Male; Ofloxacin; Primary Dysautonomias; Salmonella typhi; Tachycardia; Treatment Outcome; Typhoid Fever | 2008 |
An unusual case of knee pain: pseudogout and Abiotrophia defectiva infection.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Arthritis, Infectious; Calcium Pyrophosphate; Ceftriaxone; Chondrocalcinosis; Drug Therapy, Combination; Humans; Knee Joint; Male; Ofloxacin; Streptococcal Infections; Streptococcus | 2008 |
[Primary Salmonella vascular graft infection and conservative treatment].
Topics: Aged; Amikacin; Anti-Bacterial Agents; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Blood Vessel Prosthesis; Cefotaxime; Ceftriaxone; Combined Modality Therapy; Device Removal; Drug Therapy, Combination; Femoral Artery; Humans; Laparotomy; Male; Ofloxacin; Oxacillin; Popliteal Artery; Prosthesis-Related Infections; Recurrence; Salmonella Infections; Salmonella typhimurium; Shock, Septic | 2008 |
Study of antibiotic resistance by efflux in clinical isolates of Pseudomonas aeruginosa.
Topics: Ceftazidime; Ceftriaxone; Ciprofloxacin; Drug Resistance, Microbial; Drug Resistance, Multiple; Ethidium; Microbial Sensitivity Tests; Ofloxacin; Pseudomonas aeruginosa | 2007 |
Medical resource utilization among community-acquired pneumonia patients initially treated with levofloxacin 750 mg daily versus ceftriaxone 1000 mg plus azithromycin 500 mg daily: a US-based study.
Topics: Adult; Aged; Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Community-Acquired Infections; Drug Therapy, Combination; Female; Health Resources; Humans; Least-Squares Analysis; Levofloxacin; Male; Middle Aged; Ofloxacin; Pneumonia; Practice Guidelines as Topic; Societies, Medical; United States | 2009 |
Splenic abscess due to Salmonella enterica Serotype typhi in a young adult.
Topics: Abdominal Abscess; Anti-Bacterial Agents; Ceftriaxone; Humans; Male; Metronidazole; Ofloxacin; Salmonella typhi; Spleen; Splenic Diseases; Typhoid Fever; Young Adult | 2008 |
[Arthritis caused by Burkholderia cepacia].
Topics: Aged, 80 and over; Anti-Bacterial Agents; Arthritis, Infectious; Burkholderia cepacia; Burkholderia Infections; Ceftriaxone; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Gentamicins; Humans; Knee Joint; Male; Ofloxacin; Synovial Fluid | 2010 |
[Treatment of community-acquired pneumonia in adults: ertapenem versus cefditoren?].
Topics: Adult; Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Cephalosporins; Community-Acquired Infections; Ertapenem; Humans; Ofloxacin; Pneumonia, Bacterial | 2010 |
Trends in antimicrobial resistance in Shigella species in Karachi, Pakistan.
Topics: Adolescent; Adult; Age Factors; Ampicillin; Anti-Infective Agents; Ceftriaxone; Child; Child, Preschool; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Dysentery, Bacillary; Humans; Infant; Microbial Sensitivity Tests; Nalidixic Acid; Ofloxacin; Pakistan; Shigella; Trimethoprim, Sulfamethoxazole Drug Combination | 2009 |
CEM-101 activity against Gram-positive organisms.
Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Clarithromycin; Drug Resistance, Bacterial; Drug Synergism; Erythromycin; Gentamicins; Gram-Positive Bacteria; Ketolides; Macrolides; Microbial Sensitivity Tests; Ofloxacin; Staphylococcus aureus; Staphylococcus epidermidis; Streptococcus pneumoniae; Streptococcus pyogenes; Triazoles; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2010 |
[A case of Salmonella enterica serovar typhi with decreased susceptibility to ciprofloxacin].
Topics: Anti-Bacterial Agents; Bacteremia; Ceftriaxone; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Humans; India; Male; Microbial Sensitivity Tests; Middle Aged; Nalidixic Acid; Ofloxacin; Randomized Controlled Trials as Topic; Recurrence; Salmonella paratyphi A; Salmonella typhi; Travel; Typhoid Fever | 2010 |
Topical treatment with incision and antiseptic may prevent the severity of Japan spotted fever.
Topics: Aged; Anti-Infective Agents, Local; Ceftriaxone; Erythema; Female; Fever; Humans; Minocycline; Ofloxacin; Povidone-Iodine; Rickettsia Infections; Severity of Illness Index; Treatment Outcome | 2010 |
Brain abscesses during Proteus vulgaris bacteremia.
Topics: Anti-Bacterial Agents; Antiphospholipid Syndrome; Bacteremia; Brain; Brain Abscess; Ceftriaxone; Community-Acquired Infections; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Ofloxacin; Physical Examination; Proteus Infections; Proteus vulgaris; Tomography, X-Ray Computed | 2011 |
[A case of acute phlegmonous gastritis causing gastroparesis and cured with medical treatment alone].
Topics: Acinetobacter; Acute Disease; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Cefotaxime; Ceftriaxone; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Gastritis; Gastroparesis; Gastroscopy; Humans; Imipenem; Klebsiella oxytoca; Male; Ofloxacin; Pneumonia; Tomography, X-Ray Computed | 2011 |
[Chlamydia trachomatis: The enemy of the Fallopian tube].
Topics: Adolescent; Adult; Ceftriaxone; Chlamydia Infections; Chlamydia trachomatis; Doxycycline; Fallopian Tube Diseases; Female; Humans; Infertility, Female; Metronidazole; Ofloxacin; Prevalence; Young Adult | 2011 |
Salmonella Colindale osteomyelitis in an immunocompetent female patient.
Topics: Abscess; Adolescent; Anti-Bacterial Agents; Bacterial Typing Techniques; Ceftriaxone; Combined Modality Therapy; Debridement; Female; Humans; Immunocompetence; Ofloxacin; Osteomyelitis; Salmonella; Salmonella Infections; Tibia | 2012 |
Epididymo-orchitis: an unusual manifestation of salmonellosis.
Topics: Abscess; Administration, Intravenous; Administration, Oral; Ceftriaxone; Ciprofloxacin; Developing Countries; Epididymitis; Humans; India; Male; Middle Aged; Ofloxacin; Orchitis; Salmonella Infections; Salmonella paratyphi A; Treatment Outcome | 2012 |
Lack of significant variability among different methods for calculating antimicrobial days of therapy.
Topics: Adult; Anti-Infective Agents; Ceftriaxone; Drug Dosage Calculations; Humans; Kidney Diseases; Ofloxacin; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Time Factors; Tobramycin; Vancomycin | 2012 |
[Levofloxacin hepatotoxicity].
Topics: Adult; Alanine Transaminase; Anti-Bacterial Agents; Aspartate Aminotransferases; Bronchiectasis; Bronchitis; Ceftriaxone; Chemical and Drug Induced Liver Injury; Drug Substitution; gamma-Glutamyltransferase; Hepatomegaly; Humans; Hyperbilirubinemia; Levofloxacin; Male; Ofloxacin | 2013 |
Simultaneous determination of the combined drugs of ceftriaxone sodium, metronidazole, and levofloxacin in human urine by high-performance liquid chromatography.
Topics: Ceftriaxone; Chromatography, High Pressure Liquid; Ethylamines; Humans; Hydrogen-Ion Concentration; Least-Squares Analysis; Levofloxacin; Methanol; Metronidazole; Ofloxacin; Phosphates; Potassium Compounds; Reproducibility of Results; Sensitivity and Specificity | 2012 |
[Diagnostic and treatment patterns in management of male patients with nongonococcal urethritis: results of Russian multicentral cross-sectional study].
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antiprotozoal Agents; Azithromycin; Ceftriaxone; Chlamydia trachomatis; Cross-Sectional Studies; Doxycycline; Fluconazole; Guideline Adherence; Humans; Josamycin; Male; Metronidazole; Middle Aged; Mycoplasma genitalium; Mycoplasma hominis; Ofloxacin; Polymerase Chain Reaction; Practice Guidelines as Topic; Retrospective Studies; Russia; Trichomonas vaginalis; Ureaplasma urealyticum; Urethra; Urethritis | 2012 |
Extensive dural sinus thrombosis and bilateral lateral rectus palsy as an uncommon complication of chronic suppurative otitis media.
Topics: Abducens Nerve Diseases; Adolescent; Anti-Bacterial Agents; Ceftriaxone; Chronic Disease; Fibrinolytic Agents; Heparin; Humans; Magnetic Resonance Imaging; Male; Ofloxacin; Otitis Media, Suppurative; Sinus Thrombosis, Intracranial | 2013 |
Antimicrobial susceptibilities of clinical isolates of HACEK organisms.
Topics: Anti-Bacterial Agents; Ceftriaxone; Gram-Negative Bacteria; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin | 2013 |
Bilateral orbital preseptal cellulitis after combined adenotonsillectomy and strabismus surgery--case report and pathogenetic hypothesis.
Topics: Adenoidectomy; Anti-Bacterial Agents; Ceftriaxone; Child, Preschool; Dexamethasone; Drug Therapy, Combination; Glucocorticoids; Humans; Male; Ofloxacin; Ophthalmologic Surgical Procedures; Orbital Cellulitis; Strabismus; Tobramycin; Tonsillectomy; Treatment Outcome | 2013 |
Pelvic inflammatory disease in the adolescent: understanding diagnosis and treatment as a health care provider.
Topics: Adolescent; Anti-Bacterial Agents; Arkansas; Ceftriaxone; Centers for Disease Control and Prevention, U.S.; Child; Diagnosis, Differential; Diagnostic Errors; Doxycycline; Ethnicity; Female; Guideline Adherence; Humans; International Classification of Diseases; Levofloxacin; Metronidazole; Ofloxacin; Outpatient Clinics, Hospital; Pain; Pelvic Inflammatory Disease; Practice Guidelines as Topic; Recurrence; Retrospective Studies; Sexually Transmitted Diseases; Symptom Assessment; United States; Uterine Cervicitis; Young Adult | 2013 |
Phylogenetic study of metallo-β-lactamase producing multidrug resistant Pseudomonas aeruginosa isolates from burn patients.
Topics: Amikacin; Anti-Bacterial Agents; beta-Lactamases; Burns; Ceftazidime; Ceftriaxone; Cilastatin; Clavulanic Acid; Colistin; Disk Diffusion Antimicrobial Tests; Drug Combinations; Drug Resistance, Multiple, Bacterial; Genetic Variation; Humans; Imipenem; Minocycline; Netilmicin; Ofloxacin; Phylogeny; Polymerase Chain Reaction; Pseudomonas aeruginosa; Tigecycline | 2015 |
Orbital cellulitis and multiple abscess formation after strabismus surgery.
Topics: Abscess; Administration, Topical; Anti-Bacterial Agents; Ceftriaxone; Child, Preschool; Drug Therapy, Combination; Erythromycin; Exotropia; Eye Infections, Bacterial; Female; Humans; Infusions, Intravenous; Magnetic Resonance Imaging; Oculomotor Muscles; Ofloxacin; Ophthalmologic Surgical Procedures; Orbital Cellulitis; Staphylococcal Infections; Staphylococcus aureus | 2016 |
Antibiotic treatment patterns, costs, and resource utilization among patients with community acquired pneumonia: a US cohort study.
Topics: Adult; Aged; Ambulatory Care; Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Community-Acquired Infections; Female; Humans; Male; Middle Aged; Ofloxacin; Pneumonia, Bacterial; Retrospective Studies; Risk Assessment | 2017 |
Use of Rifabutin as an Alternative Agent for Human Brucellosis: A Case Report.
Topics: Adult; Antibiotics, Antitubercular; Brucellosis; Ceftriaxone; Drug Therapy, Combination; Female; Humans; Ofloxacin; Rifabutin; Sacroiliitis; Tomography, X-Ray Computed | 2018 |
Antibiotic use in chicken farms in northwestern China.
Topics: Adult; Animals; Anti-Bacterial Agents; Ceftriaxone; Chickens; China; Cross-Sectional Studies; Drug Misuse; Farms; Female; Health Knowledge, Attitudes, Practice; Health Policy; Humans; Logistic Models; Male; Middle Aged; Norfloxacin; Ofloxacin; One Health; Oxytetracycline; Socioeconomic Factors; Surveys and Questionnaires; Young Adult | 2020 |
Bactericidal activities and post-antibiotic effects of ofloxacin and ceftriaxone against drug-resistant Salmonella enterica serovar Typhi.
Topics: Anti-Bacterial Agents; Ceftriaxone; Humans; Microbial Sensitivity Tests; Ofloxacin; Pharmaceutical Preparations; Salmonella typhi | 2021 |
A random survey of the prevalence of falsified and substandard antibiotics in the Lao PDR.
Topics: Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Doxycycline; Humans; Laos; Ofloxacin; Prevalence; Sulfamethoxazole; Trimethoprim | 2022 |